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Recent work on the Molicutes that associate with genital tract tissues focuses on four species that may be of interest in potential
maternal, fetal, and neonatal infection and in contributing to adverse pregnancy outcomes. Mycoplasma hominis and Ureaplasma
urealyticum have historically been the subject of attention, but Mycoplasma genitalis which causes male urethritis in addition to
colonizing the female genital tract and the division of Ureaplasma into two species, urealyticum and parvum, has also added new
taxonomic clarity. The role of these genital tract inhabitants in infection during pregnancy and their ability to invade and infect
placental and fetal tissue is discussed. In particular, the role of some of these organisms in prematurity may be mechanistically
related to their ability to induce inﬂammatory cytokines, thereby triggering pathways leading to preterm labor. A review of this
intensifying exploration of the mycoplasmas in relation to pregnancy yields several questions which will be important to examine
in future research.
1.Introduction
Mycoplasma hominis, Ureaplasma urealyticum have had sev-
eral decades of history among experts in genital tract
infectious disease with indications that the former can be
part of the normal ﬂora of sexually experienced women
and both may play a role in chorioamnionitis, salpingitis,
bacterialvaginosis,andpostpartumendometritis.Despitean
abundance of reports on these organisms, work progressed
slowly, mainly due to the fastidiousness and technically
challenging culture methods needed to link the organism to
clinicalconditions.Theavailabilityofmolecularmethodshas
substantially altered our ability to derive valid information
about the pathogenic potential of these bacteria which lack
rigid cell walls (Molicutes, speciﬁcally the family Mycoplas-
mataceae).
More recently, interest in Mycoplasma genitalium has
developed among basic scientists; not so much because of it
being an organism that can infect the human reproductive
tract—though it can, but because it is a self-replicating
microorganism with a minimally sized genome and has
been sequenced, showing how little DNA is actually needed
to permit microbial life. The genome of this organism is
580,000 base pairs and contains 482 genes. By comparison
the genome of Neisseria gonorrhea is about 2.2 million base
pairs. Despite attention in Mycoplasma genitalium being
largely to interest in its genetic organization and the focus
of the creation of a synthetic Mycoplasma by the J. Craig
Venter Institute, it has also been given substantial attention
as a genital tract colonizer or pathogen.
In this paper, we will review contemporary information
about Mycoplasma and Ureaplasma with special attention to
the manner in which these organisms may be associated with
premature birth and related syndromes. As a convenience, at
timeswhenbothgeneraarebeingreferredto,thetermgenital
mycoplasmas will be used to denote that the discussion
encompasses all the Mycoplasmataceae that may occur in the
female genital tract.
2. Common Pathways to PretermLabor and
Adverse Pregnancy Outcome
Inﬂammatory reactions within the genital tract tissues of
the pregnant female represent a common pathway that leads
to delivery, not only when labor is initiated prematurely,2 Infectious Diseases in Obstetrics and Gynecology
but also when it occurs spontaneously at term. While a
complete discussion of the details of parturition could run
to a book-length work, just a few points require mention
as background for the discussion of the very small bacteria
considered here that can contribute to preterm labor and
delivery.
First, the components of parturition include, uter-
ine activity, cervical eﬀacement, and rupture of the fetal
membranes, while mechanical processes at one level are
ultimately dependent on mediators that are released prior
to these mechanical actions occurring. Several sources of
proinﬂammatorysubstancescanbenotedincludingstresson
the mother or fetus, blood borne infection of the placenta
(even if occult), short cervix allowing vaginal ﬂora to be
in abnormally close proximity to the fetal membranes,
overdistention of the uterus, and altered vaginal ﬂora in
which elevated concentrations of proinﬂammatory microor-
ganisms may be present. Recent observations indicate that
inﬂammatory cells invade the chorion and amnion in
both premature and term labor, and inﬂammatory cells
may be a source of inﬂammatory mediators [1]. Uterine
contractions are driven by prostaglandin in the form of
PGF2-a which is increased in the amniotic ﬂuid in preterm
labor both when the inﬂammation is associated with positive
microbial culture and even in the absence of positive culture
[2].
As a result, there is concern about microbial stimuli that
can lead to inﬂammatory reactions in the gravid uterus
as these could initiate the cascade of events leading to
precipitous delivery. The source of such inﬂammation-
inducing insults includes speciﬁc bacteria whether acquired
exogenously (such as STD pathogens) or endogenously
(altered ecology of the normal ﬂora), expanding numbers
of certain bacteria which are otherwise normal inhabitants
of the healthy host, escape of normal bacteria to otherwise
privileged sites to anatomic locations in proximity to the
fetus, and speciﬁc genetic backgrounds of the pregnant
womanthatallowmodiﬁedresponsestomicrobialchallenge.
Any of these might incite inﬂammation in the cervix,
membranes, amniotic ﬂuid, placenta, or cord. Indeed, even
the fetus may become part of generating an inﬂammatory
response that may result in preterm labor.
Thus, attention may be paid to speciﬁc organisms,
such as the Mycoplasmas and Ureaplasmas, even though
they may elicit adverse pregnancy outcomes in ways that
are functionally similar to the way other bacteria elicit
inﬂammatory reactions that lead to preterm labor and birth.
Nevertheless, there is a second layer of concern and
interest in preterm birth elicited by excursions in micro-
bial populations. If preterm birth occurs secondary to an
inﬂammatory stimulus occurring because of an expanded
bacterial population, the infant at the time of birth may
be exposed to a qualitatively or quantitatively abnormal
bacterial challenge and if premature, this exposure could
contribute to the pathologies that are well known among
preterm infants. Waites and colleagues noted that the
association, though not the actual causality of Ureaplasmas
withprematureinfantbronchopulmonarydysplasia,haswell
been established [3], and even as more data is collected on
etiologic and mechanistic connections, more eﬃcacious and
targeted therapies are needed.
3.Mycoplasma genitalium (MG)
A m o n gs e x u a lp a r t n e r si nar e c e n ts t u d yo fM e x i c a n
American and African American individuals, there was a
9.5 and 10.6% infection rate with MG in women and men,
respectively, and symptoms of urethritis among men, but
lack of symptoms in women [4]. Further underscoring the
role of this organism in male nongonococcal urethritis, an
Australian case control study recently published indicated
that MG prevalence was 10% among cases versus 2% among
controls, but C. trachomatis among cases was 33.5% [5].
The organism has also been incriminated as a cause of
cervicitis. In a study of a cross section of women attending
an STD clinic in Baltimore, the rate of MG in women
with cervicitis was 28.6%, while C. trachomatis was 15.8%
among cervicitis patients, and MG was found in 19.2%
of all patients in the study, while Chlamydia trachomatis
was present in 11.1%. Although coinfections were common,
multiple logistic regression revealed that only MG coloniza-
tion was signiﬁcantly associated with cervicitis [6]. Among
nonpregnant women, MG also has been associated with
salpingitisandinastudyofCefoxitintreatmentofsalpingitis,
failure to eliminate symptoms was attributed to eradicate
MG [7]. And in a study of Swedish women undergoing
elective termination, postabortal salpingitis was associated
with MG colonization in 2.8% of women, furnishing an
odds ratio above 6-fold compared to noncolonized women
[8].
In an animal study, rapid dissemination from vaginal
deposition of MG to the upper genital tract and to joints was
observed to occur in a mouse model of infection, providing
a hint that this mycoplasma may behave through pathogenic
pathways similar to other mycoplasmas that have been found
in salpingitis [9]. Indeed, a study by Short and coworkers,
who studied 22MG monoinfected women, with pelvic
inﬂammatory disease, comparing them to 172 gonococcal
andorchlamydialinfectedwomenfoundnaturalhistoryand
epidemiologic characteristics of the three infections to be
similar [10].
The role of MG in premature birth is less well deﬁned
and is complicated because it may be superimposed on the
carriage of other organisms also implicated as causes or
at least associates of adverse pregnancy outcome. A recent
case-control study from analyzed pregnant women tested for
several genital tract pathogens and after multivariate analysis
found that young maternal age and MG colonization were
independent risk factors for preterm birth [11].
One of the early studies conducted in London looked at
more than 1200 pregnant women and found that coloniza-
tion rate by MG was only 0.7% and only one miscarriage,
and no evidence of a connection with preterm birth was
discovered. In a study from Japan, investigators also failed to
ﬁnd an association of MG with prematurity, although they
did associate Ureaplasma parvum (and not U. urealyticum)
with preterm birth and late spontaneous abortion [12].
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amniotic ﬂuids and were unable to ﬁnd PCR evidence of MG
[13]. Thus, the preponderance of evidence suggests that MG,
while quite prevalent, is more important in male urethritis
and nonpregnant women than in pregnancy. Nevertheless,
indications that MG may have a role in adverse pregnancy
outcomes were reported in very recent papers, suggesting
that as technology improves and diligence in searching for
associations with MG in pregnancy increases, new evidence
of its signiﬁcance may yet emerge.
4.Mycoplasma hominis andUreaplasma
urealyticum (MH andUU)
These two organisms are considered together because much
of the literature related to these organisms has developed
together. In 1985, a Canadian study by Ebmil and Pereria
noted that cervical cultures of MH and UU revealed that
the organisms were found simultaneously in women from
family planning and prenatal clinics much more frequently
than ether was found alone [14].
What was ﬁrst learned about the importance of these
organisms in the female genital tract was based on detection
by arduous culture methods and in some cases by antibody
studies. The early work on these organisms suggested,
MH was a marker for sexual activity, with higher preva-
l e n c ei nc e r v i c o v a g i n a lc u l t u r e so fs e x u a l l ya c t i v ew o m e n
than prior to sexual debut. UU was typically thought of
as a more virulent organism. These organisms have been
associated with bacterial vaginosis and salpingitis, but their
role in gynecologic infections has often been a matter
of dispute. In a recent survey of women from a sexual
health clinic in Australia, the rates of colonization with UU
and MH were 6.1 and 13.7%, respectively, however, an-
other Ureaplasma, U. parvum, was found in 57% of women
[15].
The term “genital mycoplasmas” is taxonomically impre-
cise way of referring jointly to MH and UU, and because
of its use in the literature, it will also be used in the
followingparagraphs.Currentliteraturerelatedtothegenital
mycoplasmas reports on observations that are made both
by culture-based detections and by molecular diagnostic
methods. Relatively few reports rely on antibodies to these
organisms for detection or diagnosis. There is little doubt
thatmolecularmethodshaverevolutionizedourunderstand-
ing of these microorganisms, because when culture and
molecular detection are used simultaneously, methods such
as PCR seem to oﬀer great sensitivity. As noted by Oh
et al. [16], cultivation missed most Ureaplasma present in
genital tract tissues in women with placental insuﬃciency.
Such individuals would be expected to have a high rate
of genital mycoplasma migration into the amniotic ﬂuid
or fetal membranes, but by culture, 91% of women with
PCR evidence of Ureaplasma had negative cultures for the
organism [17].
Despite limitations in methods, the preponderance of
reports implicates UU more frequently in relationship to
prematurity-linked conditions. Thus, for preterm premature
rupture of the fetal membranes, preterm labor, intra-
amnioticinfection,chorioamniointis,funisitis,andplacental
invasion, the presence of genital mycoplasmas is often
interpreted as these organisms having a role in pathogenesis.
This may be an overinterpretation, but cautious investigators
describe these epidemiologic associations as inﬂuencing the
risk of adverse pregnancy outcomes. Several reports men-
tionedbelowwillemphasizetheapparentgreaterimportance
of UU compared to MH.
It is appropriate to note that in a Czech study of 225
women with pPROM, 68% had cervical colonization by
UU compared to 17% among control patients, and 28%
of pPROM patients were colonized by MH compared to
15% among control patients [18]. Kasper et al. [19]m a d ea n
extensive analysis of microbial ﬂora with several categories
ofvaginalconditionsincludingBV,partialBV,alteredvaginal
ﬂora,aerobicvaginosis,andgenitalMycoplasma colonization
and reported that after 24 weeks gestation, MH was a risk
factor for preterm birth (as were partial BV and abnormal
vaginal ﬂora characterized by a diminution of Lactobacillus).
In contrast, another study [20] of 977 pregnancies in which
Nugent scoring was done found that 14% of individuals had
a high (8 or greater) Nugent score and this was associated
withpretermbirth,butgenitalmycoplasmacolonizationwas
not. Interestingly UU colonization was much higher than
was high Nugent score (UU was found in 88% and MH was
present in only 3%).
A study of nearly 2000 women in Brussels found a
pretermbirthrateof4.9%,and53.6%ofthosewhodelivered
prematurely showed UU colonization. In this study, the
description of abnormal bacterial ﬂora often accompanied
colonization by UU. Although logistic regression showed
a signiﬁcant risk associated with UU, it did not show a
commensuraterisk associatedwithwhattheauthorsreferred
to as abnormal ﬂora [21]. Another recent study of 150
women with pPROM reported that UU was present in
96% but was only found in 32% of women who did
not experience membrane rupture [22]. Ureaplasma will
certainly not be the only threat during pregnancy as noted
by a study of bacterial invasion of the amniotic ﬂuid, but
it is striking that in 15 women for whom cervical insuﬃ-
ciency was the predisposing cause to amniotic invasion, 7
women had intra-amniotic bacteria (one or more species)
and 5 of these 7 had UU [23]. Finally, a recent study
of placental cultures from Japan found that among 151
placentas from pregnancies that ended with spontaneous
preterm birth before 32 completed weeks, 63 were culture
positive for Ureaplasma and 83% of these showed histo-
logic chorioamnionitis, whereas only 30% of Ureaplasma
culture negative placentas showed signs of chorioamnionitis
[24].
The preceding paragraphs support the idea that both
species of genital mycoplasmas may infect the products of
conception,butpredominantly,UUseemsthemorefrequent
and by inference the more virulent of the two opportunistic
organisms. This raises further questions as to what consti-
tutes virulence among the genital mycoplasmas and whether
virulence can be measured. Further, and probably related, is
how the genital mycoplasmas are able to elicit the adverse
pregnancy outcomes, and in particular, how may they be
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5.Ureaplasma parvum (UP)
The taxonomic designation of UP as phylogentically distinct
from other mycoplasmas is a relatively recent occurrence
and makes backward looks at the literature challenging. It is
possible that earlier papers subsumed this organism under
UU, but it is also possible that its presence was missed.
Therefore, emphasis will be placed in the next paragraphs
on the literature that has recognized the separate status of
UP.
A modern innovation in microbiology is using the
genetic material rather than phenotypic information as a
point from which to understand the organism. A ground-
breaking paper by Perevre and colleagues [25]c o m p a r e d
genomes of MH, MG, and UP and identiﬁed 247 coding
sequences that were common to the three organisms and
for UP there were 280 coding sequences unique to that
organism. In addition, analysis of the genomes revealed
the energy metabolism, and growth substrates were dis-
tinct for the three species. This is notable because it
implies that despite living in a common environment, they
each derive their energy from the host milieu in diﬀerent
ways.
Given the availability of reagents that can detect UP, it
maybeexpectedthatalargenumberofreportswillbeseenin
the future that articulate the ecology of this organism in the
human genital tract. For example, a recent report found that
in healthy nonpregnant women UP was identiﬁed in 57% of
their cohort which was far more prevalent than any of the
other genital mycoplasmas, a host of viruses or Chlamydia,
Trichomonas, or Group B Streptococcus [15]. The organism
was conﬁrmed in other populations as well. In a study of
women postrenal transplant genital mycoplasmas were more
prevalent (40%) than in nontransplant women (27.5%) with
UP showing a strong dominance [26]. A group in Poland
recently reported on the prevalence of UP in women in
relation to cervical pathology and found that among 143
women with squamous intraepithelial lesions compared to
39healthycontrols,mycoplasmaswerefoundin34%ofcases
with UP predominating.
Several reports have focused on the frequency of
mycoplasmas including UP in the male genital tract with
potential relationships to urethritis, male infertility, and sex-
ual transmission. These topics are not immediately germane,
but the literature suggests a role for male partners in female
infections.
The arrival of a new taxonomic classiﬁcation is usually
met with the question of what speciﬁc role does this newly
named organism play in clinical infections? For UP there
is emerging evidence that it may play a role in infections
of pregnancy or in eliciting conditions associated with
prematurity. A recent study indicated that there is a dose-
related intra-amniotic inﬂammatory response to UP and
that this is related not only to pPROM, preterm labor,
and chorioamnionitis, but also to early onset sepsis in the
baby and bronchopulmonary dysplasia [27]. Kataoka’s study
from 2006 indicated a high prevalence of UP and a statis-
tical association with late abortion and early preterm birth
[12].
6. ClinicalFeaturesof
Host-Mycoplasma Interaction and
Mechanisms of Adverse Outcomes
The pathogenicity of mycoplasmas in the female genital tract
waspreviouslyconﬁrmedbythepresenceofantimycoplasma
antibodies among women with intra-amniotic infection
and postpartum fevers [28], but currently the details of
immunologic networks are better known and it is possible
to make more direct links to clinical outcomes.
Even before speciﬁc immunity in the form of antibody
is engaged, the host employs mechanisms for recognizing
molecular motifs that lead to intracellular signaling and
upregulation of host defense factors. A system of recognition
factors includes the toll-like receptors or TLRs which have
been identiﬁed in the genital tract [29]. Activation of TLRs
results in the expression of cytokines that can elicit inﬂam-
mation and phagocytosis leading to antigen presentation
and ultimately speciﬁc immunity. If we are able to conduct
cell culture experiments that indicate that speciﬁc molecular
motifs known as PAMPs or pathogen-associated molecular
patterns exist in genital mycoplasmas, it could explain how
these organisms elicit the inﬂammatory reactions that can
lead to labor.
It is appropriate to explore the question of whether
genital mycoplasmas have the ability to ligand TLRs with
the result of that inﬂammatory mediators are elaborated.
MG is known to upregulate the key signaling molecule
NFκB through the Toll 2 and 6 receptors on epithelial
cells [16]. This research also indicated vaginal epithelial
cells were less responsive than cervical epithelial cells. In
a study of detergent-extractable macrophage stimulating
activityfromUU,activationofToll2and4showedactivation
o fam o n o c y t ec e l ll i n e[ 30]. Trophoblast cells from term
placentas are also activated (producing elevated NFκBa n d
p38 MAP kinase and ERK 1/2 in response to mycoplasma
lipoprotein [31]). These trophoblastic cells contain TLRs 2,
4,and6andthestimulationthroughexposuretolipopeptide
ultimately elicits production of COX2 and PGE2. Thus,
cervical and trophoblast tissue, are able to respond to
common elements of mycoplasma, namely the lipopeptide
portion of the cell membrane and evidence points to the
TLR2 being a key receptor in this process. Cytokines are part
of a highly regulated network and include proinﬂammatory
factors as well as anti-inﬂammatory factors. Proinﬂam-
matory cytokines have been associated with amnion and
placental infections. Interleukins 1β,6 ,a n d8a sw e l la sT N F -
α [16, 32], are typically elevated in amniotic ﬂuid, cord
blood, and expression in tissues that simultaneously contain
bacterial DNA [33]. The cytokines, prostaglandin synthetic
pathway (cyclo-oxygenase), and prostaglandins provide a
mechanistic connection between the inﬂammatory stimulus
and the ultimate initiation of labor.
7.Mycoplasma Virulence
Certainlythesubstancesthatelicitaninﬂammatoryresponse
may be considered among the most important virulence fac-
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factors may be important in the pathogenic potential of
these normally opportunistic organisms. The bulk of the
existing literature on this topic relates to the hundreds
of mycoplasmas that infect animals, where long standing
interest in veterinary medicine has existed. There is evidence
to suggest that membrane active substances with hemolytic
activity are found in all the arginine using mycoplasmas
[34] such as MH. Adherence factors may be predicted as
are typical for epithelial microorganisms and like other
mucosal pathogens, an IgA protease has been reported for
UU [35]. While the diﬃculty in culturing and working
with mycoplasmas in the same way that more conventional
organisms are studied has probably limited the pursuit of
virulence factors, the annotated genomes of these organisms
will allow the prediction of the presence of factors that may
be analogous to virulence factors in other organisms and will
provide a fertile area of research for theoretical biologists.
8. RemainingIssues
The story of mycoplasmas that are found in pregnant women
and speciﬁcally in the reproductive tract and in occasional
association with adverse pregnancy outcome is an incom-
plete and sometimes confusing story. One complicating
factor is the fact that the mycoplasmas can reside in the
normal ﬂora and when pregnancy complications that could
have a microbial etiology arise, it is often diﬃcult or even
illogical to incriminate one microorganism. The diﬃculty in
understanding the mycoplasmas in relation to prematurity
is much like the diﬃculty in connecting preterm birth in
women with bacterial vaginosis (BV) to the BV. While the
condition has a statistical association with preterm birth,
BV itself involves organisms that are part of the normal
ﬂora. While the numbers and relationships among the
normal vaginal ﬂora organisms are altered in BV, there is
a natural tendency among schooled clinicians singling out
an individual organism as an object of therapeutic drug
treatment, to think that an organism such as Gardnerella
vaginalis may be the important target when in reality a
complex bacterial milieu seems to be important and some
bacterial species that may be a part of the process have only
been identiﬁed relatively recently (Atopobium vaginae,f o r
one).
Realizing that mycoplasmas are also part of the bacterial
milieu of BV, we again face the dilemma of whether we can
incriminate the mycoplasmas alone for adverse pregnancy
outcomes or must consider only the entirety of the ﬂora
as responsible. Increasingly, multivariable analysis is being
used to tease individual factors out of complex collections
of epidemiologic, statistical, and clinical data. In this way,
certain organisms that are part of the normal ﬂora can be
associated as independent risk factors for clinical conditions.
Moreover, it will be important for those who follow this
ﬁeld to pay close attention to the questions being asked
and speciﬁc associations being hypothesized because there
is a diﬀerence in whether an association is being made
between mycoplasmas and prematurity, and/or low birth-
weight, and/or amnionitis, and/or amniotic ﬂuid infection,
and/or preterm rupture of the membranes. Likewise, the
clinical question could be whether one or more of these
outcomes is related to genital tract colonization by a par-
ticular organism or whether a speciﬁc tissue (e.g., amnion,
placenta, amniotic ﬂuid) must be infected to result in clinical
symptoms.
Future research will undoubtedly continue to dissect
details about the role of mycoplasmas in adverse preg-
nancy outcome through statistical means and more speciﬁc
questions. But a limitation of these kinds of investigation
will be dependent on the success with which mycoplasmas
are identiﬁed among cohorts of patients to be studied.
Mycoplasmashavebeenincludedasasubjectofinvestigation
for many years, their presence was ﬁrst based on culture, and
because the culture techniques are challenging, diﬀerences in
technicalexpertisebetweenlaboratoriesmayhaveslowed the
process of discovery and certainty about the clinical role of
these organisms.
Currently, we have the advantage of molecular detection
methods. Polymerase chain reaction is now commonly
used to detect the presence of these organisms with great
speciﬁcity, and when used in a quantitative mode has the
ability to make inferences about dose response relationships
in clinical situations. The ability to exploit molecular meth-
ods to examine microbe interactions with their receptors
and transduction of cellular signals and upregulation of
cytokines and other eﬀector molecules from susceptible
tissues puts us on the edge of a clear understanding of the
interaction of the genital mycoplasmas and host cells at the
most fundamental level. New opportunities for therapeutic
interventions should follow understanding infectious mech-
anisms in extreme detail.
Onelastpointtobemadeintheeverincreasingemphasis
on medicine delivered by health care teams, we should
be reminded that the issues of infectious disease leading
to preterm birth and other complications of pregnancy
do not end with the delivery. The fact is that the infant
may be born with infection that threatens survival, but the
microorganisms that may help precipitate labor may also
participate in other signiﬁcant problems of the premature
infant. The growing literature on this topic is beyond
the scope of this paper, but associations of mycoplasmas
with bronchopulmonary dysplasia, fetal respiratory distress
syndrome [36], and intraventricular hemorrhage are begin-
ning to appear in the literature and should be watched
carefully over the coming years. These signiﬁcant advances
in understanding of the consequences of infection should
heighten the determination of obstetricians and neonatal
intensivists to focus on good communication for the beneﬁt
of both mother and her oﬀspring.
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